U.S. Senate to vote this spring on lowering insulin prices -Senator Schumer

WASHINGTON, March 22 (Reuters) – U.S. Senate Majority Leader Chuck Schumer said on Tuesday he intends to hold votes this spring on a bill that would cap the cost of insulin, a life-sustaining diabetes drug.The legislation would place a $35 monthly cap on what patients pay for insulin, Schumer said, and would be paired with another emerging bipartisan plan to drive down the price “in a more comprehensive way, including having the uninsured protected,” Schumer told reporters.The Democratic leader added that he is working to place the legislation on the floor of the full Senate following a recess that ends in late April.